AAPS Co-Sponsors Workshop Focusing On Modified Release Drug Products

September 23, 2009

Therapeutic equivalence to have being highlighted in event co-sponsored by the Product Quality Research Institute and the International Pharmaceutical Federation

WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific body of approximately 12,000 members employed in assiduity, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum conducive to the exchange of knowledge mixed scientists to enhance their contributions to general body of mankind health. AAPS offers timely according to principles programs, on-going education, information resources, opportunities in opposition to networking, and professional development. This workshop is co-sponsored with the Product Quality Research Institute (PQRI) and International Pharmaceutical Federation (FIP).

WHAT: In union with PQRI and FIP, AAPS is pleased to present the workshop Challenges and Opportunities in Establishing Scientific and Regulatory Standards according to Assuring Therapeutic Equivalence of Modified Release Products. This two-day event will canvass some of the challenges presented by the complexity of Modified Release (MR) dosage forms. The workshop inclination consist of talks by experts from the pharmaceutical industry, academia, and the U.S. Food and Drug Administration.

WHY:This workshop aims to convene pharmaceutical scientists from academia, industry and regulatory agencies to criticise advances and regulations related to MR dosage forms, examine current and emerging issues, and identify critical paths to establishing scientific and regulatory standards for ensuring therapeutic equivalence and curative interchangeability of MR products.

WHEN: October 1-2, 2009
Sheraton Inner Harbor Hotel
Baltimore, MD, USA

Source:
Joseph Catapano
American Association of Pharmaceutical Scientists